CBBCX
Price
$7.19
Change
+$0.05 (+0.70%)
Updated
Jun 2 closing price
Net Assets
1.86B
VIVIX
Price
$83.17
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

CBBCX vs VIVIX

Header iconCBBCX vs VIVIX Comparison
Open Charts CBBCX vs VIVIXBanner chart's image
CBBCX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
CBBCX vs. VIVIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBBCX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 238B vs. CBBCX (1.86B). VIVIX pays higher dividends than CBBCX: VIVIX (1.87) vs CBBCX (0.00). CBBCX was incepted earlier than VIVIX: CBBCX (33 years) vs VIVIX (28 years). CBBCX (1.69) is less costly to investors than VIVIX (0.03). CBBCX is a more actively managed with annual turnover of: 65.00 vs. VIVIX (8.00). CBBCX has a lower initial minimum investment than VIVIX: CBBCX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 23.24 vs. CBBCX (13.51). VIVIX return over 5 years is better than : 50.71 vs. CBBCX (4.21).
CBBCXVIVIXCBBCX / VIVIX
Total Expense Ratio1.650.035,500%
Annual Report Gross Expense Ratio1.690.035,633%
Fund Existence33 years28 years-
Gain YTD9.84610.67092%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B238B1%
Annual Yield % from dividends0.001.87-
Returns for 1 year13.5123.2458%
Returns for 3 years22.3353.1842%
Returns for 5 years4.2150.718%
Returns for 10 years33.63150.4222%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAZEX21.980.08
+0.37%
Oakmark International Small Cap R6
SGIIX88.030.09
+0.10%
First Eagle Global I
FRIFX12.52N/A
N/A
Fidelity Real Estate Income
BRTNX79.58N/A
N/A
Bretton Fund
ARRQX21.18N/A
N/A
Aristotle Value Equity R6